Judge Affirms Bar On Teva Discovery In Aricept IP Suit

Law360, New York (June 29, 2010, 4:59 PM EDT) -- Teva Pharmaceuticals USA Inc. has lost its bid to overturn a magistrate judge's denial of its request for access to communications between plaintiff Eisai Co. Ltd. and the U.S. Patent and Trademark Office in a patent infringement suit over Alzheimer's drug Aricept.

Judge Garrett E. Brown of the U.S. District Court for the District of New Jersey on Monday rejected Teva's appeal of Magistrate Judge Esther Salas' Dec. 8 order denying Teva's motion to compel discovery related to its inequitable conduct defense.

Judge Brown affirmed Judge...
To view the full article, register now.